Watch Ticker

Novavax Inc

Go to Novavax Inc Website

$6.68

0.12 (1.83%)

Live

Previous Close

$6.56

Day Range

$0 - $0

Previous Day Range

$6.36 - $6.605

Market Cap

$1.1 billion USD

Day Vol.

Previous Day Vol.

5.4 million

Currency

USD

Primary Exchange

Nasdaq

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish su...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Moderna's mRNA Flu Vaccine Outperforms Standard Shots

Moderna reported positive Phase 3 trial results for its mRNA-1010 flu vaccine, showing 26.6% higher efficacy compared to standard flu shots in adults over 50, with mild adverse reactions and strong performance across different influenza strains.

Related tickers: MRNA, NVAX.

Read Full Article

Sns Insider - Vaccine Adjuvants Market to Reach USD 5.43 Billion by 2032 Due to Increasing Demand for Enhanced Vaccine Efficacy and Global Immunization Programs – SNS Insider

The global vaccine adjuvants market is projected to grow from USD 3.83 billion in 2024 to USD 5.43 billion by 2032, with a 4.47% CAGR, driven by increasing vaccine efficacy demands and global immunization programs.

Related tickers: GSK, NVAX, DVAX.

Read Full Article

Trending Tickers

Please sign in to view